Looking Into Ascendis Pharma's Recent Short Interest
Portfolio Pulse from Benzinga Insights
Ascendis Pharma (NYSE:ASND) has seen a 10.56% decrease in its short percent of float, now at 7.88%. This is higher than its peers' average of 5.70%. The decrease in short interest may indicate a shift in market sentiment.
September 26, 2024 | 3:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Ascendis Pharma's short interest has decreased by 10.56%, now at 7.88% of float, which is higher than its peers' average of 5.70%. This decrease may indicate a shift towards a more bullish sentiment.
The decrease in short interest suggests that fewer investors are betting against Ascendis Pharma, which could indicate a more positive outlook. However, the short interest is still higher than its peers, which may keep some bearish sentiment.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100